METABOLIC EVIDENCE OF VIABLE MYOCARDIUM IN REGIONS WITH REDUCED WALL THICKNESS AND ABSENT WALL THICKENING IN PATIENTS WITH CHRONIC ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION

被引:74
作者
PERRONEFILARDI, P
BACHARACH, SL
DILSIZIAN, V
MAUREA, S
MARINNETO, JA
ARRIGHI, JA
FRANK, JA
BONOW, RO
机构
[1] NHLBI, CARDIOL BRANCH,BLDG 10,ROOM 7B 15, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA
[2] NIH, CTR CLIN, BETHESDA, MD 20892 USA
关键词
D O I
10.1016/0735-1097(92)90153-E
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reduced end-diastolic wall thickness with absent systolic wall thickening has been reported to represent nonviable myocardium in patients with chronic coronary artery disease. To assess whether reduced regional end-diastolic wall thickness and absent wall thickening accurately identify nonviable myocardium, 25 patients with ischemic left ventricular dysfunction (ejection fraction at rest 27 +/- 10 %) underwent positron emission tomography with oxygen-15-labeled water and 18fluorodeoxyglucose to assess metabolic activity and spin-echo gated nuclear magnetic resonance imaging to measure regional end-diastolic wall thickness and wall thickening. The presence of metabolic activity was defined as 18fluorodeoxyglucose uptake (corrected for partial volume) >50 % of that in normal regions. Of 355 myocardial regions evaluated, 266 were hypokinetic or normokinetic at rest and 89 were akinetic (that is, absent wall thickening). 18Fluorodeoxyglucose uptake was observed in 97 % of the hypokinetic and normokinetic regions and in 74 % of the akinetic regions. End-diastolic wall thickness was greater in akinetic regions with than in those without 18fluorodeoxyglucose uptake (11 +/- 4 vs. 7 +/- 3 mm, p < 0.01). The highest values for sensitivity and specificity of end-diastolic wall thickness in predicting the absence of metabolic activity in akinetic regions were 74 % and 79 %, respectively, and corresponded to an end-diastolic threshold of 8 mm. However, the positive predictive accuracy was only 55% and did not improve for other end-diastolic wall thickness values. In all myocardial regions, there was only a weak correlation between 18fluorodeoxyglucose activity and either end-diastolic wall thickness (r = 0.17) or wall thickening (r = 0.32). Thus, metabolic activity is present in many regions with reduced end-diastolic wall thickness and absent wall thickening. These data indicate that assessment of regional anatomy and function may be inaccurate in distinguishing asynergic but viable myocardium from nonviable myocardium.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 28 条
[1]  
BACHARACH SL, 1989, COMPUT CARDIOL, P219
[2]   NONINVASIVE QUANTITATION OF MYOCARDIAL BLOOD-FLOW IN HUMAN-SUBJECTS WITH OXYGEN-15-LABELED WATER AND POSITRON EMISSION TOMOGRAPHY [J].
BERGMANN, SR ;
HERRERO, P ;
MARKHAM, J ;
WEINHEIMER, CJ ;
WALSH, MN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (03) :639-652
[3]   QUANTIFICATION AND VALIDATION OF LEFT-VENTRICULAR WALL THICKENING BY A 3-DIMENSIONAL VOLUME ELEMENT MAGNETIC-RESONANCE-IMAGING APPROACH [J].
BEYAR, R ;
SHAPIRO, EP ;
GRAVES, WL ;
ROGERS, WJ ;
GUIER, WH ;
CAREY, GA ;
SOULEN, RL ;
ZERHOUNI, EA ;
WEISFELDT, ML ;
WEISS, JL .
CIRCULATION, 1990, 81 (01) :297-307
[4]   REVERSIBLE ASYNERGY - HISTOPATHOLOGIC AND ELECTROGRAPHIC CORRELATIONS IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
BODENHEIMER, MM ;
BANKA, VS ;
HERMANN, GA ;
TROUT, RG ;
PASDAR, H ;
HELFANT, RH .
CIRCULATION, 1976, 53 (05) :792-796
[5]   IDENTIFICATION OF VIABLE MYOCARDIUM IN PATIENTS WITH CHRONIC CORONARY-ARTERY DISEASE AND LEFT-VENTRICULAR DYSFUNCTION - COMPARISON OF THALLIUM SCINTIGRAPHY WITH REINJECTION AND PET IMAGING WITH F-18 FLUORODEOXYGLUCOSE [J].
BONOW, RO ;
DILSIZIAN, V ;
CUOCOLO, A ;
BACHARACH, SL .
CIRCULATION, 1991, 83 (01) :26-37
[6]   REAL-TIME RADIONUCLIDE CINEANGIOGRAPHY IN NONINVASIVE EVALUATION OF GLOBAL AND REGIONAL LEFT-VENTRICULAR FUNCTION AT REST AND DURING EXERCISE IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
BORER, JS ;
BACHARACH, SL ;
GREEN, MV ;
KENT, KM ;
EPSTEIN, SE ;
JOHNSTON, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (15) :839-844
[7]   REVERSIBLE ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION - EVIDENCE FOR THE HIBERNATING MYOCARDIUM [J].
BRAUNWALD, E ;
RUTHERFORD, JD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1467-1470
[8]   REGIONAL PERFUSION, GLUCOSE-METABOLISM, AND WALL MOTION IN PATIENTS WITH CHRONIC ELECTROCARDIOGRAPHIC Q-WAVE INFARCTIONS - EVIDENCE FOR PERSISTENCE OF VIABLE TISSUE IN SOME INFARCT REGIONS BY POSITRON EMISSION TOMOGRAPHY [J].
BRUNKEN, R ;
TILLISCH, J ;
SCHWAIGER, M ;
CHILD, JS ;
MARSHALL, R ;
MANDELKERN, M ;
PHELPS, ME ;
SCHELBERT, HR .
CIRCULATION, 1986, 73 (05) :951-963
[9]   DETECTION AND LOCALIZATION OF RECENT MYOCARDIAL-INFARCTION BY MAGNETIC-RESONANCE-IMAGING [J].
FILIPCHUK, NG ;
PESHOCK, RM ;
MALLOY, CR ;
CORBETT, JR ;
REHR, RB ;
BUJA, LM ;
JANSEN, DE ;
REDISH, GR ;
GABLIANI, GI ;
PARKEY, RW ;
WILLERSON, JT .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (03) :214-219
[10]   F-18 DEOXYGLUCOSE AND STRESS N-13 AMMONIA POSITRON EMISSION TOMOGRAPHY IN ANTERIOR WALL HEALED MYOCARDIAL-INFARCTION [J].
FUDO, T ;
KAMBARA, H ;
HASHIMOTO, T ;
HAYASHI, M ;
NOHARA, R ;
TAMAKI, N ;
YONEKURA, Y ;
SENDA, M ;
KONISHI, J ;
KAWAI, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (15) :1191-1197